News Category
Lantern Pharma's upcoming webcast signals continued momentum in its AI-driven oncology pipeline and commercial AI platform, underscoring its strategic...
Lantern Pharma's receipt of a U.S. patent allowance for methods using a three-gene biomarker signature to select patients for LP-184 treatment advance...
Formycon AG and OneSource Specialty Pharma have entered a strategic manufacturing partnership to leverage OneSource's biologics facility in India for ...
Lantern Pharma's launch of the ZetaOmics platform, an autonomous computational biologist agent, positions the company to commercialize its AI technolo...
Academy Hunt has expanded its platform to include over 1,000 AI course comparisons, providing structured data on fees, certifications, and formats to ...
Quantum Genesis AI Corp. issued a clarification to distinguish research activities by Quantumzyme LLP from its own operations, reaffirming its intelle...
Lantern Pharma closed a $4.4 million registered direct offering, with potential additional proceeds from warrants, to support its AI-powered precision...
Lantern Pharma has expanded its predictBBB platform into a Large Quantitative Model, offering researchers a real-time molecular intelligence engine fo...
Lantern Pharma will showcase its withZeta.ai multi-agentic AI co-scientist platform in a live public demonstration on April 30, 2026, highlighting its...
